Filing Details

Accession Number:
0001209191-11-043269
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-08-09 19:14:49
Reporting Period:
2011-08-09
Filing Date:
2011-08-09
Accepted Time:
2011-08-09 19:14:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
949858 Oncogenex Pharmaceuticals Inc. OGXI In Vitro & In Vivo Diagnostic Substances (2835) 954343413
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1217456 Stewart H Parker 1522 217Th Place Se
Suite 100
Bothell WA 98021
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-08-09 3,000 $10.09 3,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct